|
1
|
Nabors LB, Portnow J, Ahluwalia M,
Baehring J, Brem H, Brem S, Butowski N, Campian JL, Clark SW,
Fabiano AJ, et al: Central nervous system cancers, version 3.2020,
NCCN clinical practice guidelines in oncology. J Natl Compr Canc
Netw. 18:1537–1570. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Theeler BJ and Gilbert MR: Advances in the
treatment of newly diagnosed glioblastoma. BMC Med.
13(293)2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tykocki T and Eltayeb M: Ten-year survival
in glioblastoma. A systematic review. J Clin Neurosci. 54:7–13.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Stupp R, Taillibert S, Kanner A, Read W,
Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K,
et al: Effect of tumor-treating fields plus maintenance
temozolomide vs maintenance temozolomide alone on survival in
patients with glioblastoma: A randomized clinical trial. JAMA.
318:2306–2316. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Stupp R, Taillibert S, Kanner AA, Kesari
S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink
KL, et al: Maintenance therapy with tumor-treating fields plus
temozolomide vs temozolomide alone for glioblastoma: A randomized
clinical trial. JAMA. 314:2535–2543. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ostrom QT, Cioffi G, Waite K, Kruchko C
and Barnholtz-Sloan JS: CBTRUS statistical report: Primary brain
and other central nervous system tumors diagnosed in the United
States in 2014-2018. Neuro Oncol. 23 (12 Suppl 2):iii1–iii105.
2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lacroix M, Abi-Said D, Fourney DR,
Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch
SJ, Holland E, et al: A multivariate analysis of 416 patients with
glioblastoma multiforme: Prognosis, extent of resection, and
survival. J Neurosurg. 95:190–198. 2001.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Curran WJ Jr, Scott CB, Horton J, Nelson
JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO,
Krisch RE, et al: Recursive partitioning analysis of prognostic
factors in three Radiation Therapy Oncology Group malignant glioma
trials. J Natl Cancer Inst. 85:704–710. 1993.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Walker MD, Green SB, Byar DP, Alexander E,
Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey
J Jr, et al: Randomized comparisons of radiotherapy and
nitrosoureas for the treatment of malignant glioma after surgery. N
Engl J Med. 303:1323–1329. 1980.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ozdemir-Kaynak E, Qutub AA and
Yesil-Celiktas O: Advances in glioblastoma multiforme treatment:
New models for nanoparticle therapy. Front Physiol.
9(170)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Roy S, Lahiri D, Maji T and Biswas J:
Recurrent glioblastoma: Where we stand. South Asian J Cancer.
4:163–173. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Stavrinou P, Kalyvas A, Grau S, Hamisch C,
Galldiks N, Katsigiannis S, Kabbasch C, Timmer M, Goldbrunner R and
Stranjalis G: Survival effects of a strategy favoring second-line
multimodal treatment compared to supportive care in glioblastoma
patients at first progression. J Neurosurg. 131:1136–1141.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kavalieratos D, Corbelli J, Zhang D,
Dionne-Odom JN, Ernecoff NC, Hanmer J, Hoydich ZP, Ikejiani DZ,
Klein-Fedyshin M, Zimmermann C, et al: Association between
palliative care and patient and caregiver outcomes: A systematic
review and meta-analysis. JAMA. 316:2104–2114. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Thier K, Calabek B, Tinchon A, Grisold W
and Oberndorfer S: The last 10 days of patients with glioblastoma:
Assessment of clinical signs and symptoms as well as treatment. Am
J Hosp Palliat Care. 33:985–988. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Walbert T and Khan M: End-of-life symptoms
and care in patients with primary malignant brain tumors: A
systematic literature review. J Neurooncol. 117:217–224.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Witteler J, Schild SE and Rades D:
Palliative radiotherapy of primary glioblastoma. In Vivo.
35:483–487. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Check JH, Wilson C, Cohen R and Sarumi M:
Evidence that Mifepristone, a progesterone receptor antagonist, can
cross the blood brain barrier and provide palliative benefits for
glioblastoma multiforme grade IV. Anticancer Res. 34:2385–2388.
2014.PubMed/NCBI
|
|
20
|
Ferrell BR, Temel JS, Temin S, Alesi ER,
Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T,
et al: Integration of palliative care into standard oncology care:
American society of clinical oncology clinical practice guideline
update. J Clin Oncol. 35:96–112. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Triebel KL, Martin RC, Nabors LB and
Marson DC: Medical decision-making capacity in patients with
malignant glioma. Neurology. 73:2086–2092. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Brinkman-Stoppelenburg A, Rietjens JA and
van der Heide A: The effects of advance care planning on
end-of-life care: A systematic review. Palliat Med. 28:1000–1025.
2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Houben CHM, Spruit MA, Groenen MTJ,
Wouters EFM and Janssen DJA: Efficacy of advance care planning: A
systematic review and meta-analysis. J Am Med Dir Assoc.
15:477–489. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Senderovich H, Waicus S and Mokenela K:
Evading seizures: Phenobarbital reintroduced as a multifunctional
approach to end-of-life care. Case Rep Oncol. 15:218–224.
2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Harrison RA, Ou A, Naqvi SMAA, Naqvi SM,
Weathers SS, O'Brien BJ, de Groot JF and Bruera E: Aggressiveness
of care at end of life in patients with high-grade glioma. Cancer
Med. 10(8387)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lin E, Rosenthal MA, Eastman P and Le BH:
Inpatient palliative care consultation for patients with
glioblastoma in a tertiary hospital. Intern Med J. 43:942–945.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Glynn AM, Rangaswamy G, O'Shea J, Dunne M,
Grogan R, MacNally S, Fitzpatrick D and Faul C: Glioblastoma
Multiforme in the over 70's: ‘To treat or not to treat with
radiotherapy?’. Cancer Med. 8:4669–4677. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hemminger LE, Pittman CA, Korones DN,
Serventi JN, Ladwig S, Holloway RG and Mohile NA: Palliative and
end-of-life care in glioblastoma: Defining and measuring
opportunities to improve care. Neurooncol Pract. 4:182–188.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kuchinad KE, Strowd R, Evans A, Riley WA
and Smith TJ: End of life care for glioblastoma patients at a large
academic cancer center. J Neurooncol. 134:75–81. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sundararajan V, Bohensky MA, Moore G,
Brand CA, Lethborg C, Gold M, Murphy MA, Collins A and Philip J:
Mapping the patterns of care, the receipt of palliative care and
the site of death for patients with malignant glioma. J Neurooncol.
116:119–126. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ziobro M, Rolski J, Grela-Wojewoda A,
Zygulska A and Niemiec M: Effects of palliative treatment with
temozolomide in patients with high-grade gliomas. Neurol Neurochir
Pol. 42:210–215. 2008.PubMed/NCBI
|
|
32
|
Oberndorfer S, Lindeck-Pozza E, Lahrmann
H, Struhal W, Hitzenberger P and Grisold W: The end-of-life
hospital setting in patients with glioblastoma. J Palliat Med.
11:26–30. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Reimer P, Bremer C, Horch C, Morgenroth C,
Allkemper T and Schuierer G: MR-monitored LITT as a palliative
concept in patients with high grade gliomas: Preliminary clinical
experience. J Magn Reson Imaging. 8:240–244. 1998.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Pompili A, Telera S, Villani V and Pace A:
Home palliative care and end of life issues in glioblastoma
multiforme: Results and comments from a homogeneous cohort of
patients. Neurosurg Focus. 37(E5)2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kim JY, Peters KB, Herndon JE II and
Affronti ML: Utilizing a palliative care screening tool in patients
with glioblastoma. J Adv Pract Oncol. 11:684–692. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wu A, Ruiz Colón G, Aslakson R, Pollom E
and Patel CB: Palliative care service utilization and advance care
planning for adult glioblastoma patients: A systematic review.
Cancers (Basel). 13(2867)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Golla H, Nettekoven C, Bausewein C, Tonn
JC, Thon N, Feddersen B, Schnell O, Böhlke C, Becker G, Rolke R, et
al: Effect of early palliative care for patients with glioblastoma
(EPCOG): A randomised phase III clinical trial protocol. BMJ Open.
10(e034378)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ironside SA, Sahgal A, Detsky J, Das S and
Perry JR: Update on the management of elderly patients with
glioblastoma: A narrative review. Ann Palliat Med. 10:899–908.
2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Teoli D, Schoo C and Kalish VB: Palliative
Care. StatPearls [Internet]. 2023 Feb 6 [cited 2024 Apr 15];
Available from: https://www.ncbi.nlm.nih.gov/books/NBK537113/.
|
|
40
|
Pando A, Patel AM, Choudhry HS, Eloy JA,
Goldstein IM and Liu JK: Palliative care effects on survival in
glioblastoma: Who receives palliative care? World Neurosurg.
170:e847–e857. 2023.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Mohammed S, Dinesan M and Ajayakumar T:
Survival and quality of life analysis in glioblastoma multiforme
with adjuvant chemoradiotherapy: A retrospective study. Rep Pract
Oncol Radiother. 27:1026–1036. 2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Seekatz B, Lukasczik M, Löhr M, Ehrmann K,
Schuler M, Keßler AF, Neuderth S, Ernestus RI and van Oorschot B:
Screening for symptom burden and supportive needs of patients with
glioblastoma and brain metastases and their caregivers in relation
to their use of specialized palliative care. Support Care Cancer.
25:2761–2770. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Barbaro M, Blinderman CD, Iwamoto FM,
Kreisl TN, Welch MR, Odia Y, Donovan LE, Joanta-Gomez AE, Evans KA
and Lassman AB: Causes of death and end-of-life care in patients
with intracranial high-grade gliomas: A retrospective observational
study. Neurology. 98:e260–e266. 2022.PubMed/NCBI View Article : Google Scholar
|
